Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Cash flows from operating activities:
Net loss	$ (2,481,326)	$ (1,771,827)	$ (6,751,958)	$ (4,539,100)
Adjustments to reconcile net loss to net cash used in operating activities:
Non-cash stock compensation issued for services			282,633	80,300
Non-cash stock compensation issued to directors and employees			274,698	400,675
Fair value of stock options issued to employees			1,151,800	852,187
Amortization of discount on notes payable			1,014,959	678,043
Amortization of leasehold right of use asset			63,047	16,930
Gain on extinguishment of debt			(159,126)
Loss from equity method investment	113,492		113,492
Depreciation and amortization			23,680	8,938
Changes in assets and liabilities:
Accounts receivable			(28,960)	3,859
Interest receivable			(579)
Inventory			(25,018)	(140,097)
Prepaid expenses and other current assets			(75,661)	(22,757)
Accounts payable and accrued expenses			186,656	84,448
Accrued compensation			(65,415)	139,575
Deferred revenue			(535,714)	(535,715)
Leasehold liability			(21,091)	(16,067)
Accrued interest			34,811	34,870
Income taxes payable			(1,062)	(912)
Net cash used in operating activities			(4,518,808)	(2,954,823)
Cash from investing activities:
Payments to acquire property, plant, and equipment			(744,247)	(20,528)
Payments to acquire patents			(17,633)
Payments to acquire trademarks			(20,909)	(37,480)
Investment in joint ventures			(252,884)	(32,674)
Payment for notes receivable			(200,000)
Net cash used in investing activities			(1,235,673)	(90,682)
Cash from financing activities:
Proceeds from the sale of notes payable				2,998,905
Proceeds from notes payable				157,620
Proceeds from warrant exercise			123,562
Proceeds from unit purchase option exercise			246,278
Principal payment on notes payable – related parties				(40,000)
Principal payment on notes payable				(295,000)
Payment of stock issuance expenses				(106,316)	$ (1,800,000)
Net cash provided by financing activities			369,840	2,715,209
Increase (decrease) in cash and cash equivalents			(5,384,641)	(330,296)
Cash and cash equivalents at beginning of period			10,097,760	1,238,585	1,238,585
Cash and cash equivalents at end of period	$ 4,713,119	$ 908,289	4,713,119	908,289	$ 10,097,760
Supplemental disclosure of cash flow information:
Interest			29,125	83,134
Taxes			912	1,062
Noncash activities:
Common stock issued upon note payable and accrued interest conversion			1,243,788
Common stock issued for prepaid services			168,850
Cashless exercise of warrants			9
Cashless exercise of unit purchase options			8
Initial ROU asset and lease liability			1,374,956
Fair value of options issued for debt				868,985
Fair value of warrants issued with debt				999,464
Fair value of warrants issued related to debt placement				47,293
Beneficial conversion feature on convertible notes				$ 1,208,163